Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 8, 2025 • 4:30 AM ET

Date/Time Source News Release
06/30/2025 06:48 PM EDT Newsfile Telo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President
06/18/2025 08:30 AM EDT Newsfile Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma
05/27/2025 08:30 AM EDT Newsfile Telo Genomics Receives New Client Tier under Intellectual Property Ontario (IPON)
05/15/2025 08:30 AM EDT Newsfile European Hematology Association Accepts Abstract from Telo Genomics for Presentation at The 2025 Congress
04/10/2025 08:30 AM EDT Newsfile Telo Genomics Announces Acceptance of its MRD Validation Data in Multiple Myeloma for ASCO 2025
04/04/2025 08:30 AM EDT Newsfile Telo Genomics Announces Appointment of John Farlinger to Its Board of Directors
02/27/2025 08:30 AM EST Newsfile Telo Genomics Announces Expanded Partnership with Trusted Health Advisors
12/23/2024 04:00 PM EST Newsfile Telo Genomics Closes Oversubscribed $2.5 Million Private Placement
11/19/2024 08:45 AM EST Newsfile Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON)
10/30/2024 08:45 AM EDT Newsfile Telo Genomics Expands its Strategic Collaboration with Mayo Clinic
Page